BRIEF published on 06/12/2026 at 10:36, 16 days 9 hours ago OHB and Helsing Form Alliance for Europe's Space Sector OHB SE Technological Sovereignty Helsing Space Start-ups European Space Sector
BRIEF published on 06/12/2026 at 10:36, 16 days 9 hours ago OHB et Helsing forment une alliance pour le secteur spatial européen OHB SE Souveraineté Technologique Helsing Start-ups Spatiales Secteur Spatial Européen
BRIEF published on 06/12/2026 at 10:34, 16 days 9 hours ago KHD Humboldt Wedag Secures Major US Contract Frankfurt Stock Exchange Engineering Sector KHD Humboldt Wedag Major US Contract Cement Facility
BRIEF published on 06/12/2026 at 10:34, 16 days 9 hours ago KHD Humboldt Wedag décroche un important contrat américain Bourse De Francfort Secteur De L'ingénierie Cimenterie KHD Humboldt Wedag Contrat Américain Majeur
BRIEF published on 06/12/2026 at 10:05, 16 days 9 hours ago Kora Partners with IATA to Enhance Airline Payments in Africa Intégration Africa Airlines Payment Infrastructure IATA
BRIEF published on 06/12/2026 at 10:05, 16 days 9 hours ago Kora s'associe à l'IATA pour améliorer les paiements aériens en Afrique Intégration Afrique Infrastructure De Paiement IATA Compagnies Aériennes
BRIEF published on 06/12/2026 at 09:40, 16 days 10 hours ago Simcere Pharmaceutical Partners with Stanford Medicine for IPF Research Research Collaboration Innovative Therapies Idiopathic Pulmonary Fibrosis Simcere Pharmaceutical Stanford Medicine
BRIEF published on 06/12/2026 at 09:40, 16 days 10 hours ago Simcere Pharmaceutical s'associe à Stanford Medicine pour la recherche sur la fibrose pulmonaire idiopathique (FPI). Thérapies Innovantes Collaboration En Matière De Recherche Simcere Pharmaceutical Médecine De Stanford Fibrose Pulmonaire Idiopathique
BRIEF published on 06/12/2026 at 09:25, 16 days 10 hours ago CS2009: A Potential Game-Changer in Immuno-Oncology Clinical Trials Immuno-oncology ASCO 2026 CS2009 Trispecific Antibody
BRIEF published on 06/12/2026 at 09:25, 16 days 10 hours ago CS2009 : Un tournant potentiel en immuno-oncologie Essais Cliniques Immuno-oncologie ASCO 2026 CS2009 Anticorps Trispécifique
Published on 06/27/2026 at 16:50, 1 day 2 hours ago Redwood AI Announces Definitive Agreement with Quantum.IQ and Expands into Quantum Resistant Cyber Security
Published on 06/27/2026 at 01:40, 1 day 18 hours ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 1 day 19 hours ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 1 day 20 hours ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 1 day 20 hours ago Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/28/2026 at 17:26, 2 hours 19 minutes ago EQS-Adhoc: Correction of a release from 24/06/2026, 20:54 CET/CEST - Branicks Group AG sets out timetable for the publication of its 2025 annual and consolidated financial statements
Published on 06/27/2026 at 00:05, 1 day 19 hours ago EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 1 day 19 hours ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 1 day 20 hours ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 1 day 20 hours ago EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
